The epidemiology of non-Hodgkin's lymphoma

Oncogene

Volumn 23, Issue 38, 2004, Pages 6524-6534

  Fisher, Susan G ^a   Fisher, Richard I ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Epidemiology; Etiology; Non Hodgkin's lymphoma

Indexed keywords

ANTIGEN SPECIFICITY; ANTIGENICITY; AUTOIMMUNE DISEASE; B LYMPHOCYTE ACTIVATION; BLOOD TRANSFUSION; CANCER CLASSIFICATION; CANCER INCIDENCE; CELL PROLIFERATION; ENVIRONMENTAL EXPOSURE; EPSTEIN BARR VIRUS; HELICOBACTER PYLORI; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T CELL LEUKEMIA VIRUS 1; NONHODGKIN LYMPHOMA; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; SIMIAN VIRUS 40; TUMOR GROWTH; ULTRAVIOLET RADIATION; ACQUIRED IMMUNE DEFICIENCY SYNDROME; DEVELOPED COUNTRY; GENETICS; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; STATISTICS; UNITED STATES;

HELICOBACTER; HELICOBACTER PYLORI; HEPATITIS C VIRUS; HUMAN HERPESVIRUS 4; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1; SIMIAE; SIMIAN VIRUS 40;

ACQUIRED IMMUNODEFICIENCY SYNDROME; DEVELOPED COUNTRIES; HUMANS; IMMUNOSUPPRESSION; INCIDENCE; LYMPHOMA, NON-HODGKIN; UNITED STATES;

EID: 4444226528     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207843     Document Type: Review

References (110)

1. Ambinder RF, Lemas MV, Moore S, Yang J, Fabian D and Krone C. (1999). Cancer Treat. Res., 99, 27-45.
2. American Cancer Society (2001). Cancer Facts and Figures. American Cancer Society: Atlanta.
3. American Cancer Society (2004). Cancer Facts and Figures. American Cancer Society: Atlanta.
4. Baecklund E, Ekbom A, Sparén P, Feltelius N and Klareskog L. (1998). Br. Med. J., 317, 180-181.
5. Banks PM. (1992). Cancer Res., 52 (Suppl), 5453s-54535s.
6. Biggar RJ, Frisch M, Engels EA and Goedert JJ. (2001). J. Acquir. Immune Defic. Syndrome, 26, 371-376.
7. Blair A and Zahm SH. (1991). Med. State Art. Rev., 6, 335-354.
8. Blomberg J, Möller T, Olsson H, Anderson H and Jonsson M. (1993). Eur. J. Cancer, 29A, 2101-2105.
9. Breslin P, Kang HK, Lee Y, Burt V and Shepard BM. (1988). J. Occup. Med., 30, 412-419.
10. Cerhan JR, Wallace RB, Dick F, Kemp J, Parker AS, Zheng W, Sellers TA and Folsom AR. (2001). Cancer Epidemiol. Biomarkers Prev., 10, 361-368.
11. Cerhan JR, Wallace RB, Folsom AR, Potter JD, Munger RG and Prineas RJ. (1993). Ann. Intern. Med., 119, 8-15.
12. Chiu BCH, Cerhan JR, Gapstur SM, Sellers TA, Zheng W, Lutz CT, Wallace RB and Potter JD. (1999). Br. J. Cancer, 80, 1476-1482.
13. Cinque P, Brytting M, Wahren B, Linde A, Cinque P, Castagna A, Lazzarin A, Vago L, Parravicini C, Zanchetta N and Monforte AD. (1993). Lancet, 342, 398-401.
14. Cleary ML and Sklar J. (1984). Lancet, ii, 489-493.
15. Cleghorn FR, Manns A, Falk R, Hartge P, Hanchard B, Jack N, Williams E, Jaffe E, White F and Bartholomew C. (1995). J. Natl. Cancer Inst., 87, 1009-1014.
16. D'Amore F, Hasle H and Hansen KS. (1992). Hematol. Rev., 6, 183-199.
17. David H, Mendoza S, Konishi T and Miller C. (2001). Cancer Lett., 162, 57-64.
18. Del Maso L and Franceschi S. (2003). Lancet Oncol, 4, 110-116.
19. De Re V, De Vita S, Marzotto A, Rupolo M, Gloghini A, Pivetta B, Gasparotto D, Carbone A and Boiocchi M. (2000). Blood, 96, 3578-3584.
20. Devesa SS and Fears T. (1992). Cancer Res., 52 (Suppl), 5432s-54340s.
21. De Vita S, Sacco C, Sanconno D, Gloghini A, Dammacco F, Crovatto M, Santini G, Dolcetti R, Boiocchi M, Carbone A and Zagonel V. (1997). Blood, 90, 776-782.
22. Eltom MA, Jemal A, Mbulaiteye SM, Devesa SS and Biggar RJ. (2002). J. Natl. Cancer Inst., 94, 1204-1210.
23. Ferreri AJ, Guidoboni M, Ponzoni M, De Conciliis C, Dell'Oro S, Fleischhauer K, Caggiari L, Lettini AA, Dal Cin E, Ieri R, Freschi M, Villa E, Boiocchi M and Dolcetti R. (2004). J. Nat. Cancer Inst., 96, 586-594.
24. Filipovich AH, Mathur A, Kamat D and Shapiro RS. (1992). Cancer Res., 52, 5465s-5467s.
25. Fisher MS and Kripke ML. (1982). Science, 216, 1133-1134.
26. Gaidano G and Dalla-Favera R. (1997). Cancer Principles & Practice of Oncology Vol. 3. DeVita V Jr, Hellman S and Rosenberg SA. (eds). Lippincott-Raven: Philadelphia, NY, pp. 2131-2145.
27. Garabrant DH and Philbert MA. (2002). Crit. Rev. Toxicol, 32, 233-257.
28. Gisbert JP, Garcia-Buey L, Pajares JM and Moreno-Otero R. (2003). Gastroenterology, 125, 1723-1732.
29. Goedert JJ. (2000). Semin. Oncol., 27, 390-401.
30. Greenlee R, Hill-Harmon M, Murray T and Thun M. (2001). CA: Cancer J. Clin., 51, 15-36.
31. Grogan T and Miller T. (1995). Cancer Treatment Haskell CM (ed). WB Saunders: Philadelphia, 979-1005.
32. Groves FD, Linet MS, Travis LB and Devesa SS. (2000). J. Natl. Cancer Inst., 92, 1240-1251.
33. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA and Bloomfield CD. (1999). Ann. Oncol., 10, 1419-1432.
34. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B and Gatter KC. (1994). Blood, 84, 1361.
35. Harris OD, Cooke WT, Thompson H and Waterhouse JAH. (1967). Am. J. Med., 42, 899.
36. Hartge P and Devesa SS. (1992). Cancer Res., 52, 5566s-5569s.
37. Hayes HM, Tarone RE and Cantor KP. (1991). J. Natl. Cancer Inst., 83, 1226-1231.
38. Hoar SK, Blair A and Holmes FF. (1986). JAMA. 256, 1141-1147.
39. Holford TR, Zheng T, Mayne ST and McKay LA. (1992). Cancer Res., 52, 5443s-5446s.
40. Holly EA, Lele C, Bracci PM and McGrath MS. (1999). Am. J. Epidemiol., 150, 375-389.
41. Hoover RN. (1992). Cancer Res., 52, 5477S.
42. Hussell T, Isaacson P, Crabtree J and Spencer J. (1993). Lancet, 342, 571.
43. Hussell T, Isaacson PG, Crabtree JE and Spencer J. (1996). J. Pathol, 178, 122-127.
44. International Agency for Research on Cancer Monographs on the Evaluation of Carcinogenic Risks to Humans (1978). Some Aromatic Amines and Related Nitro Compounds - Hair Dyes, Colouring Agents and Miscellaneous Industrial Chemicals. Monograph 16. International Agency for Research on Cancer: Lyon, France.
45. International Agency for Research on Cancer Working Group on the Evaluation of Carcinogenic Risks to Humans (1996). Human Immunodeficiency Viruses and Human T-cell Lymphotropic Viruses. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Vol. 67 IARC Press: Lyon, pp. 67.
46. International Agency for Research on Cancer (1997). Epstein-Barr Virus and Kaposi's Sarcoma Herpesvirus/Herpesvirus 8. Monographs on the Evaluation of Carcinogenic Risks to Humans. IARC: Lyon.
47. Jacobson LP, Yamashita TE, Detels R, Margolick JB, Chmiel JS, Kingsley LA, Melnick S and Munoz A. (1999). J. Acquir. Immune Defic. Syndrome, 21 (Suppl 1), S34-S41.
48. Jeevan A and Kripke ML. (1990). Cell Immunol, 130, 32-41.
49. Jonsson V, Wiik A, Hou-Jensen K, Christiansen M, Ryder LP, Madsen HO, Geisler C, Hansen MM, Thomsen K, Vorstrup S and Svejgaard A. (1999). J. Intern. Med, 245, 277-286.
50. Kamel OW, van de Rijn M, Hanasono MM and Warnke RA. (1995). Leukemia Lymph., 16, 363.
51. Kast WM, Schreiber H and Velders MP. (1998). Encyclopedia of Life Sciences. Macmillan Reference Ltd: UK.
52. Kinlen L. (1992). Cancer Res., 52, 5474s-5476s.
53. Kirkley SA, Cowles J, Pellegrini Jr VD, Harris CM, Boyd AD and Blumberg N. (1995). Lancet, 345, 527.
54. Klein HG. (1999). Anesthesiology, 91, 861-865.
55. Kripke ML. (1994). Cancer Res., 54, 6102-6105.
56. Landers DF, Hill GE, Wong KC and Fox IJ. (1996). Anesth. Analg., 82, 187-204.
57. Lecuit M, Abachin E, Martin A, Poyart C, Pochart P, Suarez F, Bengoufa D, Feuillard J, Lavergne A, Gordon JI, Berche P, Guillevin L and Lortholary O. (2004). N. Engl. J. Med, 350, 239-248.
58. Levi F, Randimbison L, Te VC and La Vecchia C. (1996). Br. J. Cancer, 74, 1847-1850.
59. Levine AM. (1994). Ann. Oncol., 5, 29.
60. Linet MS and Pottern LM. (1992). Cancer Res., 52, 5468s-5473s.
61. Luppi M, Longo G, Ferrari MG, Ferrara L, Marasca R, Barozzi P, Morselli M, Emilia G and Torelli G. (1996). Br. J. Haematol., 94, 373-375.
62. McMichael AJ and Giles GG. (1996). Br. J. Cancer, 73, 945-950.
63. Melbye M, Adami HO, Hjalgrim H and Glimelius B. (1996). Acta Oncol, 35, 655-657.
64. Melbye M and Trichopoulos D. (2002). Textbook of Cancer Epidemiology Vol. 25. Adami H-O, Hunter D and Trichopoulos D (eds). Oxford University Press: Oxford, pp. 535-555.
65. Memon A and Doll R. (1994). Int. J. Cancer, 58, 366-368.
66. Moore RD and Chiasson RE. (1999). AIDS, 13, 1933-1942.
67. Morrow RH, Kisuule A, Pike MC and Smith PG. (1976). J. Nat. Cancer Inst., 56, 479-483.
68. Morton LM, Hartge P, Cerhan JR, Holly EA, Holford TR, Mayne ST and Zheng T. (2004). Proc. AACR, 45, 490.
69. Mueller NE, Mohar A and Evans A. (1992). Cancer Res., 52 (Suppl), 5479s-5481s.
70. Murphy EL, Figueroa JP, Gibbs WN, Holding-Cobham M, Cranston B, Malley K, Bodner AJ, Alexander SS and Blattner WA. (1991). Am. J. Epidemiol, 133, 1114-1124.
71. Nakatsuka S, Lin A, Dong Z, Nomura S, Takakuwa T, Miyazato H, Aozasa K and Osaka Lymphoma Study Group. (2003). Cancer Res., 63, 7606-7608.
72. Nelson RA, Levine AM, Marks G and Berstein L. (1997). Br. J. Cancer, 76, 1532-1537.
73. Offit K, Wong G, Filippa DA, Tao Y and Chaganti RSK. (1991). Blood, 77, 1508.
74. Opelz G and Henderson R. (1993). Lancet, 342, 1514-1516.
75. Opelz G, Sengar DP, Mickey MR and Terasaki PI. (1973). Transplant. Proc., 5, 253-259.
76. Palackdharry CS. (1994). Oncology, 8, 67-73.
77. Palella Jr FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ and Holmberg SD. (1998). N. Engl. J. Med., 338, 853-860.
78. Paltiel O, Schmit T, Adler B, Rachmilevitz EA, Polliack A, Cohen A, Haim N, Shachar MB, Epelbaum R, Barchana M, Cohen R and Ben Yehuda D. (2000). Cancer, 88, 2357-2366.
79. Parsonnet J, Hansen S, Rodriguez L, Gelb AB, Warnke RA, Jellum E, Orentreich N, Vogelman JH and Friedman GD. (1994). N. Engl. J. Med., 330, 1267-1271.
80. Pearce N. (1989). Br. J. Ind. Med., 46, 143-144.
81. Pettersson T, Pukkala E, Teppo L and Friman C. (1992). Ann. Rheum. Dis., 51,437-439.
82. Pimental D, McLaughlin L and Zepp A. (1993). Handbook of Pest Management in Agriculture Pimental D (ed), Vol. 1 CRC Press: Boca Rotan, pp. 679-680.
83. Rabkin CS, Biggar RJ and Horm JW. (1991). Int. J. Cancer, 47, 692-696.
84. Reed DM. (1902). Johns Hopkins Hosp. Rev., 10, 133.
85. Ries L, Eisner M, Kosary C, Hankey B, Miller B, Clegg L and Edwards B (eds) (2001). SEER Cancer Statistics Review. National Cancer Institute: Bethesda, MD, 1973-1998.
86. Rivas JM and Ullrich SE. (1992). J. Immunol., 149, 3865-3871.
87. Rizzo P, Carbone M, Fisher SG, Matker C, Swinnen LJ, Powers A, Di Resta I, Alkan S, Pass HI and Fisher RI. (1999). Chest, 166 (Suppl), 470S-473S.
88. SEER (2003). Surveillance, Epidemiology & End Results Program Public-Use Data 1973-2000, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch (released May).
89. Selik RM, Starcher ET and Curran JW. (1987). AIDS, 1, 175-182.
90. Shipp MA, Mauch PM and Harris NL. (1997). Cancer Principles & Practice of Oncology Vol. 3. DeVita Jr V, Hellman S and Rosenberg SA (eds). Lippincott-Raven: Philadelphia, New York, pp. 2165-2220.
91. Shivapurkar N, Harad K, Reddy J, Scheuermann RH, Xu Y, McDenna RW, Michgrub S, Kroft SH, Feng Z and Gasdar AF. (2002). Lancet, 359, 851-852.
92. Swinnen L, Costanzo-Nordin MR, Fisher SG, O'Sullivan EJ, Johnson MR, Heroux AL, Dizikes GJ, Pifarre R and Fisher RI. (1990). N. Engl. J. Med., 323, 1723.
93. Takatsuki K, Uchiyama T, Sagawa K and Yodoi J. (1976). Topics in Hematology, Adult T Cell Leukemia in Japan. Seno S, Takaku F, Iron S (eds). Excerpta Medica: Amsterdam, pp. 73-78.
94. Tavani A, La Vecchia C, Franceschi S, Serraino D and Carbone A. (2000). Eur. J. Cancer Prev., 9, 59-64.
95. Tycko B and Sklar J. (1990). Cancer Cells, 2, 1.
96. Vermeer M and Streilein JW. (1990). Photodermatol. Photoimmunol./ Photomed., 7, 258-265.
97. Vilchez RA, Madden CR, Kozinetz CA, Halvorson SJ, White ZS, Jorgensen JL, Finch CJ and Butel JS. (2002). Lancet, 359, 817-823.
98. Vink AA, Yarosh DB and Kripke ML. (1996). Photochem. Photobiol, 63, 383-386.
99. Wahl SM, Wilder RL, Katona IM, Wahl LM, Allen JB, Scher I and Decker JL. (1983). Arthritis Rheum., 26, 1076-1084.
100. Wiernik PH, Wang SQ, Hu XP, Marino P and Paietta E. (2000). Br. J. Haematol, 108, 72-79.
101. Wigle DT, Semenciw RM, Wilkins K, Riedel D, Ritter L, Morrison HI and Mao Y. (1990). J. Natl. Cancer Inst., 82, 575-582.
102. Willemze R, Kerl H, Sterry W, Berti E, Cerroni L, Chimenti S, Diaz-Peréz JL, Geerts ML, Goos M, Knobler R, Ralfkiaer E, Santucci M, Smith N, Wechsler J, van Vloten WA and Meijer CJLM. (1997). Blood, 90, 354-371.
103. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR and Isaacson PG. (1991). Lancet. 338, 1175-1176.
104. Ye BH. (2002). Cancer Investig., 18, 356-365.
105. Yosida M, Kiyokawa T, Watanabe T, Hattori S, Fujisawa J-I and Seiki M. (1985). Retroviruses in Human Lymphomal Leukemia. Miwa M (ed). Scientific Societies Press: Tokyo, Japan, pp. 39-47.
106. Zahm SH, Weisenburger DD and Babbitt PA. (1990). Epidemiology, 1, 349-356.
107. Zahm SH, Weisenburger DD, Holmes FF, Cantor KP and Blair A. (1997). Cancer Causes Control, 8, 159-166.
108. Zhang Y, Holford TR, Leaderer B, Boyle P, Zahm SH, Flynn S, Tallini G, Owens PH and Zheng T. (2004). Am. J. Epidemiol., 159, 148-154.
109. Zheng T, Mayne ST, Boyle P, Holford Tr, Liu WL and Flannery J. (1992). Cancer, 70, 840-849.
110. Zhu K, Levine RS, Gu Y, Brann EA, Hall I, Caplan LS and Baum MK. (1998). Cancer Causes Control, 9, 77-82.